Clinical Trials for Erdheim-Chester Disease

Find clinical trials for erdheim-chester disease. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

NCT ID: NCT05093335

This clinical trial is studying a special imaging technique using a substance called [68Ga]-pentixafor to help doctors see certain types of blood cancers and solid tumors more clearly. The main goa...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: New York, New York, United States

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

NCT ID: NCT04079179

This clinical trial is investigating a medication called cobimetinib for patients with Langerhans cell histiocytosis (LCH) and other related conditions that have not responded to previous treatment...

Recruiting

Phase: PHASE2 Type: interventional Locations: Orange, California, United States, New York, New York, United States +11 more

Histiocytic Disorder Follow-up Study

NCT ID: NCT05915208

The Histiocytic Disorder Follow-up Study is a clinical trial that aims to understand the long-term effects of histiocytic disorders, which are a group of rare diseases affecting the immune system. ...

Recruiting

Type: observational Locations: Birmingham, Alabama, United States

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT ID: NCT05768178

The DETERMINE Trial is studying the effects of two drugs, vemurafenib and cobimetinib, on adult patients with specific types of cancer that have a genetic change known as the BRAF V600 mutation. Wh...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Leeds, , United Kingdom +15 more

Registry for Patients with Erdheim-Chester Disease and Other Histiocytoses

NCT ID: NCT03329274

This clinical trial is focused on learning more about Erdheim-Chester Disease and other similar conditions, which are types of diseases caused by histiocytosis. Researchers want to understand the h...

Recruiting

Type: observational Locations: New York, New York, United States, New York, New York, United States

GWAS and EWAS in Patients With Erdheim-Chester Disease

NCT ID: NCT06332183

This clinical trial is studying Erdheim-Chester Disease (ECD), a rare condition where certain blood cells called histiocytes grow uncontrollably and can damage various organs in the body. Researche...

Recruiting

Type: observational Locations: Milano, Lombardia, Italy, Milano, , Italy +4 more

Subtypes and Prognostic Factors in Erdheim-Chester Disease

NCT ID: NCT06317246

This clinical trial is focused on understanding Erdheim-Chester Disease (ECD), a rare condition where certain blood cells, called histiocytes, grow out of control and invade different parts of the ...

Recruiting

Phase: NA Type: interventional Locations: Parma, , Italy, Florence, Firenze, Italy

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions